Partnervest Advisory Services’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,380
Closed -$263K 256
2018
Q3
$263K Buy
+1,380
New +$254K 0.1% 177
2018
Q2
Sell
-1,310
Closed -$221K 228
2018
Q1
$221K Buy
+1,310
New +$220K 0.11% 171
2017
Q4
Sell
-999
Closed -$205K 202
2017
Q3
$205K Sell
999
-196
-16% -$45.6K 0.1% 170
2017
Q2
$291K Sell
1,195
-396
-25% -$93.1K 0.13% 150
2017
Q1
$380K Buy
1,591
+462
+41% +$108K 0.17% 121
2016
Q4
$237K Sell
1,129
-842
-43% -$174K 0.11% 172
2016
Q3
$454K Buy
1,971
+243
+14% +$59.4K 0.21% 98
2016
Q2
$399K Buy
1,728
+630
+57% +$145K 0.2% 106
2016
Q1
$294K Buy
+1,098
New +$314K 0.15% 140

Other funds holding AGN

Partnervest Advisory Services's AGN Position: Q4 2018 in Review

Partnervest Advisory Services sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,380 shares — an estimated $263K sold.

Partnervest Advisory Services first reported a position in AGN in Q1 2016 and held it in 9 quarters. The position peaked at $454K in Q3 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Partnervest Advisory Services reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Partnervest Advisory Services sold 1,380 Allergan plc shares in Q4 2018, an estimated $263K.
  • Partnervest Advisory Services first reported a position in Allergan plc in Q1 2016 and held it in 9 quarters.
  • Partnervest Advisory Services's Allergan plc position peaked at $454K in Q3 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Partnervest Advisory Services's 13F filing for Q4 2018, filed 1 Feb 2019.